Document detail
ID

doi:10.1186/s13044-023-00173-5...

Author
Elhassan, Moawia Mohammed Ali Gismalla, Mohamed Dafalla Awadalla Mohamed, Sahar Abdelrahman Hamid Faggad, Areeg
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2023

listing date

8/30/2023

Keywords
thyroid cancer follicular carcinoma anaplastic carcinoma goiter radioactive iodine sudan women 17% thyroid cancer
Metrics

Abstract

Background In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer.

To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan.

Methods We performed a retrospective health facility–based study of patients with thyroid cancer who were treated at NCI–UG from January 2009 to December 2017.

Results A total of 139 patients with thyroid cancer were identified during the study period.

Tumors were more common among women (69%).

Goiter was the main presenting symptom (85%).

The most common type of thyroid cancer was follicular carcinoma (41%), followed by papillary carcinoma (24%), then anaplastic carcinoma (20%).

The mean age of the women was 56.3 years (SD ± 14.7), compared to 52.5 years (SD ± 16.6) for the men.

The frequencies of stage I, II, III, and IV were 17%, 22%, 16%, and 45%, respectively.

Different types of thyroidectomies were performed in 79% of the cases, lobectomy in 4%, and no surgery in 17%.

Only 28% of the cases received radioactive iodine.

Palliative chemotherapy and radiotherapy were prescribed to 17% and 37% of the cases, respectively.

Conclusion Thyroid cancer is more prevalent among women and most patients present at later stages.

The dominance of follicular type suggests that the majority of this population is iodine-deficient.

Elhassan, Moawia Mohammed Ali,Gismalla, Mohamed Dafalla Awadalla,Mohamed, Sahar Abdelrahman Hamid,Faggad, Areeg, 2023, Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience, BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?
inflammation rectal surgery overall survival complication significantly diagnostic value cancer rectal 38 siri